PYXS

Pyxis Oncology (PYXS)

Pyxis Oncology Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PYXS

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/05	05:45	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:PYXS	Pyxis Oncology Inc
2025/02/04	21:40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2025/02/04	21:30	GlobeNewswire Inc.	Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial	NASDAQ:PYXS	Pyxis Oncology Inc
2024/12/24	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2024/12/24	06:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2024/12/20	07:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2024/12/20	06:08	GlobeNewswire Inc.	Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201	NASDAQ:PYXS	Pyxis Oncology Inc
2024/11/28	07:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2024/11/21	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2024/11/21	06:05	GlobeNewswire Inc.	Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data	NASDAQ:PYXS	Pyxis Oncology Inc
2024/11/13	06:37	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PYXS	Pyxis Oncology Inc
2024/11/12	21:30	GlobeNewswire Inc.	Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024	NASDAQ:PYXS	Pyxis Oncology Inc
2024/11/11	21:00	GlobeNewswire Inc.	Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201	NASDAQ:PYXS	Pyxis Oncology Inc
2024/11/07	06:36	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:PYXS	Pyxis Oncology Inc
2024/10/24	05:53	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2024/09/26	05:08	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PYXS	Pyxis Oncology Inc
2024/09/14	05:26	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PYXS	Pyxis Oncology Inc
2024/08/29	20:30	GlobeNewswire Inc.	Pyxis Oncology to Participate in Two Upcoming Investor Conferences	NASDAQ:PYXS	Pyxis Oncology Inc
2024/08/15	05:25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PYXS	Pyxis Oncology Inc
2024/08/15	05:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2024/08/15	05:05	GlobeNewswire Inc.	Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024	NASDAQ:PYXS	Pyxis Oncology Inc
2024/07/29	21:00	GlobeNewswire Inc.	Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference	NASDAQ:PYXS	Pyxis Oncology Inc
2024/06/29	05:30	GlobeNewswire Inc.	Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PYXS	Pyxis Oncology Inc
2024/06/13	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2024/06/10	20:56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2024/06/10	20:30	GlobeNewswire Inc.	Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger	NASDAQ:PYXS	Pyxis Oncology Inc
2024/06/08	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2024/05/30	20:30	GlobeNewswire Inc.	Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference	NASDAQ:PYXS	Pyxis Oncology Inc
2024/05/14	21:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PYXS	Pyxis Oncology Inc
2024/05/14	20:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc